Analyses of potential causal contributors to increased waist/hip ratio‐associated cardiometabolic disease: A combined and sex‐stratified Mendelian randomization study.

Background: Increased waist/hip ratio (WHR) contributes to type 2 diabetes, fatty liver, dyslipidaemia, hypertension and coronary artery disease, with potential sex‐differential effects. Postulated mediators include increased lipid flux, branched‐chain amino acids, glycine and glycoprotein acetyl, but their relative contributions and sex‐specific impact on WHR‐associated cardiometabolic disease (CMD) are not established. Methods: We therefore undertook combined and sex‐stratified Mendelian randomization (MR) to assess the relative causal contributions of these mediators to WHR‐associated CMD using summary statistics from the largest genome‐wide association studies in European ancestries. Results: In sex‐combined MR analyses, increased WHR significantly reduces high‐density lipoprotein (beta = −0.416, SE = 0.029, p = 2.87E‐47), increases triglyceride (beta = 0.431, SE = 0.029, p = 1.87E‐50), type 2 diabetes (odds ratio = 2.747, SE = 0.09, p = 26E‐23), coronary artery disease (odds ratio = 1.478, SE = 0.045, p = 6.96E‐18), alanine transaminase (beta = 0.062, SE = 0.004, p = 6.88E‐67), and systolic (beta = 0.134, SE = 0.022, p = 7.81E‐10) and diastolic blood pressure (beta = 0.162, SE = 0.026, p = 5.38E‐10). Adjustment for the mediators attenuated WHR's effects, but the associations remained significant with concordant results in females. In males, a similar pattern was seen, except after adjusting for the effect of the ratio of monounsaturated fatty acid to total free fatty acid, the potential causal effect of WHR was no longer significant: high‐density lipoprotein (beta = −0.117, SE = 0.069, p =.09) and triglyceride (beta = 0.051, SE = 0.068, p =.459). Conclusions: MR suggests WHR increases the risk of CMD independent of these mediators, with the exception of dyslipidaemia in males, which is largely driven by the monounsaturated fatty acid to total free fatty acid ratio. [ABSTRACT FROM AUTHOR]